Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Alves

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Plos One|December 4, 2015
A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma CellsKetan S Patil, Indranil Basak, Ramavati Pal, et al.
Neurology|April 22, 2014
CSF Aβ42 predicts early-onset dementia in Parkinson diseaseGuido Alves, Johannes Lange, Kaj Blennow, et al.
Frontiers in Neurology|March 16, 2018
Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's DiseaseAleksander H Erga, Ingvild Dalen, Anastasia Ushakova, et al.
Journal of Neuroscience Research|June 7, 2016
LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregationShubhangi Prabhudesai, Fatima Zahra Bensabeur, Rashed Abdullah, et al.
Clinical Chemistry and Laboratory Medicine|July 31, 2016
Validation of a new assay for α-synuclein detection in cerebrospinal fluidMarthe Gurine Førland, Annika Öhrfelt, Linn Silje Oftedal, et al.
Neuroimage|June 23, 2009
White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's diseaseTuri O Dalaker, Jan P Larsen, Michael G Dwyer, et al.
Brain : a Journal of Neurology|November 15, 2024
Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathiesGonzalo S Nido, Martina Castelli, Sepideh Mostafavi, et al.
Brain : a Journal of Neurology|April 29, 2026
Comparative transcriptomics reveal molecular convergence and divergence in parkinsonian disordersSynne Geithus, Irene H Flønes, Guido Alves, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2011
Ventricular enlargement and mild cognitive impairment in early Parkinson's diseaseTuri O Dalaker, Robert Zivadinov, Deepa Preeti Ramasamy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 16, 2010
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest studyGuido Alves, Kolbjørn Brønnick, Dag Aarsland, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Plos One|December 4, 2015
A Proteomics Approach to Investigate miR-153-3p and miR-205-5p Targets in Neuroblastoma CellsKetan S Patil, Indranil Basak, Ramavati Pal, et al.
Neurology|April 22, 2014
CSF Aβ42 predicts early-onset dementia in Parkinson diseaseGuido Alves, Johannes Lange, Kaj Blennow, et al.
Frontiers in Neurology|March 16, 2018
Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's DiseaseAleksander H Erga, Ingvild Dalen, Anastasia Ushakova, et al.
Journal of Neuroscience Research|June 7, 2016
LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregationShubhangi Prabhudesai, Fatima Zahra Bensabeur, Rashed Abdullah, et al.
Clinical Chemistry and Laboratory Medicine|July 31, 2016
Validation of a new assay for α-synuclein detection in cerebrospinal fluidMarthe Gurine Førland, Annika Öhrfelt, Linn Silje Oftedal, et al.
Neuroimage|June 23, 2009
White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's diseaseTuri O Dalaker, Jan P Larsen, Michael G Dwyer, et al.
Brain : a Journal of Neurology|November 15, 2024
Single-nucleus transcriptomics reveals disease- and pathology-specific signatures in α-synucleinopathiesGonzalo S Nido, Martina Castelli, Sepideh Mostafavi, et al.
Brain : a Journal of Neurology|April 29, 2026
Comparative transcriptomics reveal molecular convergence and divergence in parkinsonian disordersSynne Geithus, Irene H Flønes, Guido Alves, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2011
Ventricular enlargement and mild cognitive impairment in early Parkinson's diseaseTuri O Dalaker, Robert Zivadinov, Deepa Preeti Ramasamy, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 16, 2010
CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest studyGuido Alves, Kolbjørn Brønnick, Dag Aarsland, et al.
Pageof 12